Financials
- Market Capitalization 27.14 B
- Employee 721
- Founded 2014
- CEO Matt Gline
- Website www.roivant.com
- Headquarter Bermuda
- FIGI N/A
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 444 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 236.56 USD | -1.02% | +3.36% | -17.82% | -47.73% | 31.65 B USD | ||
| 485 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 61.92 USD | +0.19% | +2.30% | +3.36% | +66.18% | 27.65 B USD | ||
| 497 | BNTX BioNTech SE - American Depositary Shares | 111.40 USD | -1.03% | +0.43% | +20.56% | +9.51% | 26.73 B USD | ||
| 501 | INSM Insmed Incorporated - Common Stock | 121.39 USD | -2.41% | -2.91% | +16.74% | -25.09% | 26.51 B USD |
Frequently asked questions about Roivant Sciences Ltd. Common Shares
What is the Roivant Sciences Ltd. Common Shares stock price today?
The current price of Roivant Sciences Ltd. Common Shares (ROIV) is 37.58. Over the past 24 hours, the stock has changed by +2.26%. Follow the ROIV chart for real-time price dynamics.
What is the stock ticker of Roivant Sciences Ltd. Common Shares?
Roivant Sciences Ltd. Common Shares trades under the ticker ROIV. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Roivant Sciences Ltd. Common Shares stock going up?
ROIV has changed by +1.49% over the last week, +10.89% over the last month, and +105.24% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Roivant Sciences Ltd. Common Shares?
Roivant Sciences Ltd. Common Shares currently has a market capitalization of 27.14 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Roivant Sciences Ltd. Common Shares earnings last quarter?
Last quarter, Roivant Sciences Ltd. Common Shares reported earnings of -0.26 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Roivant Sciences Ltd. Common Shares revenue for the last quarter?
Roivant Sciences Ltd. Common Shares reported quarterly revenue of 1.44 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
How many employees does Roivant Sciences Ltd. Common Shares have?
As of the latest available data, Roivant Sciences Ltd. Common Shares has 721 employees. Workforce size can provide additional context about the company's scale and operations.
What is Roivant Sciences Ltd. Common Shares EBITDA?
Roivant Sciences Ltd. Common Shares EBITDA is -365.79 M, and its EBITDA margin is -25.37 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Roivant Sciences Ltd. Common Shares stock?
You can buy Roivant Sciences Ltd. Common Shares (ROIV) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Roivant Sciences Ltd. Common Shares stock?
Investing in Roivant Sciences Ltd. Common Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ROIV chart and related analysis on metatrader.com as part of your research.